- Could High-Fructose Corn Syrup in Foods Help Speed Cancer?
- As ‘Teletherapy’ Takes Hold, Nearly 12% of Young Adults Now Undergo Psychotherapy
- Zepbound Bests Wegovy for Weight Loss in New Trial
- E. Coli Outbreak Linked to McDonald’s Quarter Pounders Declared Over
- Almost a Third of U.S. Retail Pharmacies Have Closed Since 2010
- 20th Century Lead Exposures Took Grim Toll on Americans’ Health
- American Seniors Struggle to Pay Medical Bills More Than Peers in Other Wealthy Countries
- Even Minutes-Long Exercise ‘Bursts’ Can Help Women’s Hearts
- Smoking/Vaping Combo Lowers Odds for Quitting Nicotine
- High-Dose Vitamin D Supplements Won’t Prevent Diabetes in Healthy Seniors
Longer Detox Might Work Better for Prescription Pain Med Addiction
WEDNESDAY, Oct. 23A longer period of detoxification may be more effective for people being treated for addiction to prescription painkillers called opioids, according to a small new study.
Abuse of prescription opioids such as oxycodone, hydrocodone and hydromorphone is a major public health problem in the United States. The new 12-week study, which included 70 people undergoing outpatient treatment for opioid addiction, was published online Oct. 23 in the journal JAMA Psychiatry.
For the first two weeks, all the patients took buprenorphine, a medication used to treat opioid addiction. They were then randomly assigned to slowly reduce the dose of buprenorphine over one, two or four weeks, followed by treatment with naltrexone, a medication that blocks opioid strength.
Patients in the four-week group were more likely to stop abusing opioids than those in the one-week or two-week groups, according to a journal news release.
The findings suggest that some prescription opioid abusers may respond positively to outpatient treatment with buprenorphine detoxification followed by naltrexone while undergoing behavioral therapy [counseling], study authors wrote.
“Additional controlled studies are needed to better understand the parameters of efficacious treatments for [prescription opioid] dependence, as well as to identify the individuals for whom brief vs. longer-term treatments are warranted,” concluded study authors Stacey Sigmon, of the University of Vermont, in Burlington, and colleagues.
More information
The U.S. National Institute on Drug Abuse has more about prescription drug abuse.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.